Thursday, March 31, 2016

Histone deacetylase inhibitors enhance immunotherapy in lung cancer models, researchers say

… advanced stage lung cancer and melanoma; however, only 20 percent of lung cancer patients … in solid tumors, such as lung cancer, has not been as great … represents a promising strategy for lung cancer treatment," said Amer Beg … in stage IV non-small cell lung cancer has been initiated at Moffitt …

No comments:

Post a Comment